Free Newsletter
CRO automates test item control
WuXi AppTec has purchased the Provantis preclinical software from Instem for use in a newly constructed, 314,000-square-foot toxicology facility in Suzhou, China. The contract research organization, which purchased modules for its general toxicology, clinical pathology, pathology and formulations departments, will integrate the modules and use them to aid in test item control.
The software targets researchers engaged in non-clinical evaluation studies, says an announcement. It helps users orchestrate the functions of preclinical drug safety assessment, in both GLP and non-GLP environments. The software is also compliant with 21 CFR Part 11.
Another Provantis customer is Merck Serono, which selected Provantis 8 for its R&D lab in Ivrea, Italy, and a facility in recently started a global Toxicology Data Management System. The drug maker selected Provantis 8 for its Research & Development laboratory in Ivrea, Italy and will also be upgrading to Provantis 8 at its facility in Darmstadt, Germany
- here's the WuXi announcement
- see the Merck Serono release
Related Article:
China's WuXi buys Apptec for $151M
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
